Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction.

PubWeight™: 2.11‹?› | Rank: Top 2%

🔗 View Article (PMC 4058317)

Published in Nat Biotechnol on September 08, 2013

Authors

Lior Zangi1, Kathy O Lui, Alexander von Gise, Qing Ma, Wataru Ebina, Leon M Ptaszek, Daniela Später, Huansheng Xu, Mohammadsharif Tabebordbar, Rostic Gorbatov, Brena Sena, Matthias Nahrendorf, David M Briscoe, Ronald A Li, Amy J Wagers, Derrick J Rossi, William T Pu, Kenneth R Chien

Author Affiliations

1: 1] Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts, USA. [2] Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA. [3] Department of Cardiology, Children's Hospital Boston, Boston, Massachusetts, USA. [4] Immune Disease Institute and Program in Cellular and Molecular Medicine, Children's Hospital Boston, Boston, Massachusetts, USA. [5] Boston and Harvard Stem Cell Institute, Cambridge, Massachusetts, USA. [6].

Articles citing this

Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA. Science (2014) 2.93

Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat Biotechnol (2014) 2.75

Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy. Nat Commun (2015) 2.56

Preparing the ground for tissue regeneration: from mechanism to therapy. Nat Med (2014) 1.71

Strategies for cardiac regeneration and repair. Sci Transl Med (2014) 1.08

A neonatal blueprint for cardiac regeneration. Stem Cell Res (2014) 1.01

Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals. Mol Ther (2015) 0.98

Ultrasound-triggered disruption and self-healing of reversibly cross-linked hydrogels for drug delivery and enhanced chemotherapy. Proc Natl Acad Sci U S A (2014) 0.94

Programming and reprogramming a human heart cell. EMBO J (2015) 0.92

Systematic transcriptome analysis reveals tumor-specific isoforms for ovarian cancer diagnosis and therapy. Proc Natl Acad Sci U S A (2015) 0.92

Gene therapy for the treatment of heart failure: promise postponed. Eur Heart J (2016) 0.91

Mechanisms of Cardiac Regeneration. Dev Cell (2016) 0.90

Patient genotypes impact survival after surgery for isolated congenital heart disease. Ann Thorac Surg (2014) 0.90

Driving vascular endothelial cell fate of human multipotent Isl1+ heart progenitors with VEGF modified mRNA. Cell Res (2013) 0.90

Myocardial Delivery of Lipidoid Nanoparticle Carrying modRNA Induces Rapid and Transient Expression. Mol Ther (2015) 0.89

Macro advances in microRNAs and myocardial regeneration. Curr Opin Cardiol (2014) 0.88

Biomaterials for mRNA delivery. Biomater Sci (2015) 0.87

Reprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand? EMBO Mol Med (2015) 0.85

RNA as a stable polymer to build controllable and defined nanostructures for material and biomedical applications. Nano Today (2015) 0.84

Epicardium-to-fat transition in injured heart. Cell Res (2014) 0.83

Gene therapy to treat cardiac arrhythmias. Nat Rev Cardiol (2015) 0.83

The CXCL12/CXCR4 Axis Plays a Critical Role in Coronary Artery Development. Dev Cell (2015) 0.82

Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system. Gene Ther (2016) 0.81

Poly(glycoamidoamine) Brushes Formulated Nanomaterials for Systemic siRNA and mRNA Delivery in Vivo. Nano Lett (2016) 0.81

Targeting sarcoplasmic reticulum calcium ATPase by gene therapy. Hum Gene Ther (2013) 0.81

Sequential delivery of angiogenic growth factors improves revascularization and heart function after myocardial infarction. J Control Release (2015) 0.81

Strategies and Challenges to Myocardial Replacement Therapy. Stem Cells Transl Med (2016) 0.80

Viral and Synthetic RNA Vector Technologies and Applications. Mol Ther (2016) 0.80

Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich's ataxia. Sci Rep (2016) 0.79

Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA. Cell Discov (2015) 0.79

Synthetic chemically modified mRNA (modRNA): toward a new technology platform for cardiovascular biology and medicine. Cold Spring Harb Perspect Med (2014) 0.79

New vessel formation in the context of cardiomyocyte regeneration--the role and importance of an adequate perfusing vasculature. Stem Cell Res (2014) 0.79

A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs. Ther Adv Vaccines (2014) 0.79

Efficient delivery and functional expression of transfected modified mRNA in human embryonic stem cell-derived retinal pigmented epithelial cells. J Biol Chem (2015) 0.79

An IGF1R-Dependent Pathway Drives Epicardial Adipose Tissue Formation After Myocardial Injury. Circulation (2016) 0.78

The role of tissue engineering and biomaterials in cardiac regenerative medicine. Can J Cardiol (2014) 0.78

Screening of mRNA Chemical Modification to Maximize Protein Expression with Reduced Immunogenicity. Pharmaceutics (2015) 0.78

Ultrasound-guided transthoracic intramyocardial injection in mice. J Vis Exp (2014) 0.77

Small molecules for cell reprogramming and heart repair: progress and perspective. ACS Chem Biol (2014) 0.77

Modified mRNA as a new therapeutic option for pediatric respiratory diseases and hemoglobinopathies. Mol Cell Pediatr (2015) 0.77

Deformability in the cleavage site of primary microRNA is not sensed by the double-stranded RNA binding domains in the microprocessor component DGCR8. Proteins (2015) 0.77

Developmental origin and lineage plasticity of endogenous cardiac stem cells. Development (2016) 0.77

Business: The billion-dollar biotech. Nature (2015) 0.77

Fast revascularization of the injured area is essential to support zebrafish heart regeneration. Proc Natl Acad Sci U S A (2016) 0.76

Effects of local structural transformation of lipid-like compounds on delivery of messenger RNA. Sci Rep (2016) 0.76

Messenger RNA-based therapeutics for the treatment of apoptosis-associated diseases. Sci Rep (2015) 0.76

Contribution of Fetal, but Not Adult, Pulmonary Mesothelium to Mesenchymal Lineages in Lung Homeostasis and Fibrosis. Am J Respir Cell Mol Biol (2016) 0.76

Parasite-derived neurotrophic factor/trans-sialidase of Trypanosoma cruzi links neurotrophic signaling to cardiac innate immune response. Infect Immun (2014) 0.76

Stimulating endogenous cardiac repair. Front Cell Dev Biol (2015) 0.76

Efficient expression of stabilized mRNA PEG-peptide polyplexes in liver. Gene Ther (2015) 0.76

PTEN-mRNA engineered mesenchymal stem cell-mediated cytotoxic effects on U251 glioma cells. Oncol Lett (2016) 0.76

Effects of Rosuvastatin and MiR-126 on Myocardial Injury Induced by Acute Myocardial Infarction in Rats: Role of Vascular Endothelial Growth Factor A (VEGF-A). Med Sci Monit (2016) 0.75

Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems. Gene Ther (2017) 0.75

Systemic delivery of factor IX messenger RNA for protein replacement therapy. Proc Natl Acad Sci U S A (2017) 0.75

Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo. Biomaterials (2016) 0.75

Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge. Nat Commun (2017) 0.75

V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog A Synthetic Modified mRNA Drives Reprogramming of Human Pancreatic Duct-Derived Cells Into Insulin-Secreting Cells. Stem Cells Transl Med (2016) 0.75

Generation and Assessment of Functional Biomaterial Scaffolds for Applications in Cardiovascular Tissue Engineering and Regenerative Medicine. Adv Healthc Mater (2015) 0.75

Modified RNA kick-starts cardiac repair. Nat Biotechnol (2013) 0.75

Modified mRNAs in the Cardiovascular System: A New Platform for Gene Therapy. Mol Ther (2017) 0.75

A Recombinant Collagen-mRNA Platform for Controllable Protein Synthesis. Chembiochem (2015) 0.75

Directed Differentiation of Zebrafish Pluripotent Embryonic Cells to Functional Cardiomyocytes. Stem Cell Reports (2016) 0.75

Mechanotransduction and Metabolism in Cardiomyocyte Microdomains. Biomed Res Int (2016) 0.75

Controlled Release of Collagen-Binding SDF-1α Improves Cardiac Function after Myocardial Infarction by Recruiting Endogenous Stem Cells. Sci Rep (2016) 0.75

Adipose‑derived mesenchymal stem cell‑facilitated TRAIL expression in melanoma treatment in vitro. Mol Med Rep (2016) 0.75

Human cellular CYBA UTR sequences increase mRNA translation without affecting the half-life of recombinant RNA transcripts. Sci Rep (2016) 0.75

The Probability of Inconstancy in Assessment of Cardiac Function Post-Myocardial Infarction in Mice. Cardiovasc Pharm Open Access (2016) 0.75

Individual Variation in Conditional β Cell Ablation Mice Contributes Significant Biases in Evaluating β Cell Functional Recovery. Front Endocrinol (Lausanne) (2017) 0.75

Gene delivery of hypoxia-inducible VEGF targeting collagen effectively improves cardiac function after myocardial infarction. Sci Rep (2017) 0.75

Polyamine-Mediated Stoichiometric Assembly of Ribonucleoproteins for Enhanced mRNA Delivery. Angew Chem Int Ed Engl (2017) 0.75

Approaches to augment vascularisation and regeneration of the adult heart via the reactivated epicardium. Glob Cardiol Sci Pract (2016) 0.75

mRNA mediates passive vaccination against infectious agents, toxins, and tumors. EMBO Mol Med (2017) 0.75

N1-methyl-pseudouridine in mRNA enhances translation through eIF2α-dependent and independent mechanisms by increasing ribosome density. Nucleic Acids Res (2017) 0.75

Prokineticin receptor-1-dependent paracrine and autocrine pathways control cardiac tcf21(+) fibroblast progenitor cell transformation into adipocytes and vascular cells. Sci Rep (2017) 0.75

Articles cited by this

Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet (1999) 55.63

A global double-fluorescent Cre reporter mouse. Genesis (2007) 17.86

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell (2010) 14.18

Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity (2006) 10.61

Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature (2005) 9.44

VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell (2006) 9.32

Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell (2006) 7.21

Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature (2008) 7.03

A myocardial lineage derives from Tbx18 epicardial cells. Nature (2008) 6.15

Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity (2005) 5.23

De novo cardiomyocytes from within the activated adult heart after injury. Nature (2011) 5.17

Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature (2009) 4.68

Adult cardiac-resident MSC-like stem cells with a proepicardial origin. Cell Stem Cell (2011) 3.56

The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/beta-catenin pathway. Cell Stem Cell (2007) 3.54

Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell (2011) 3.49

VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation (2000) 3.13

The serosal mesothelium is a major source of smooth muscle cells of the gut vasculature. Development (2005) 3.07

Adult mouse epicardium modulates myocardial injury by secreting paracrine factors. J Clin Invest (2011) 2.99

Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J (2002) 2.74

Generation of functional ventricular heart muscle from mouse ventricular progenitor cells. Science (2009) 2.60

GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice. Diabetes (2009) 2.58

Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol Ther (2008) 2.50

Expression of therapeutic proteins after delivery of chemically modified mRNA in mice. Nat Biotechnol (2011) 2.43

Tbx18 and the fate of epicardial progenitors. Nature (2009) 2.42

Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat Med (2002) 2.37

Distinct compartments of the proepicardial organ give rise to coronary vascular endothelial cells. Dev Cell (2012) 2.06

Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart. EMBO Mol Med (2013) 2.04

Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. Am J Pathol (2000) 1.93

Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro. J Biol Chem (1998) 1.89

Cardiac stem cell therapy and the promise of heart regeneration. Cell Stem Cell (2013) 1.86

BMP and FGF regulate the differentiation of multipotential pericardial mesoderm into the myocardial or epicardial lineage. Dev Biol (2006) 1.77

Towards regenerative therapy for cardiac disease. Lancet (2012) 1.75

Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice. Diabetes (2010) 1.71

Inducible adeno-associated virus vectors promote functional angiogenesis in adult organisms via regulated vascular endothelial growth factor expression. Cardiovasc Res (2009) 1.63

A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans. Clin Pharmacol Ther (2002) 1.63

Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin. Mol Ther (2012) 1.61

Myocardial angiogenesis after plasmid or adenoviral VEGF-A(165) gene transfer in rat myocardial infarction model. Cardiovasc Res (2006) 1.60

WT1 regulates epicardial epithelial to mesenchymal transition through β-catenin and retinoic acid signaling pathways. Dev Biol (2011) 1.53

Permeability properties of tumor surrogate blood vessels induced by VEGF-A. Lab Invest (2006) 1.51

Epicardially derived fibroblasts preferentially contribute to the parietal leaflets of the atrioventricular valves in the murine heart. Dev Biol (2012) 1.38

A selective contribution of the RIG-I-like receptor pathway to type I interferon responses activated by cytosolic DNA. Proc Natl Acad Sci U S A (2009) 1.35

Isolation, culture, and functional analysis of adult mouse cardiomyocytes. Methods Mol Med (2007) 1.31

Efficient and stable transduction of cardiomyocytes after intramyocardial injection or intracoronary perfusion with recombinant adeno-associated virus vectors. Circulation (1999) 1.28

Modified Foxp3 mRNA protects against asthma through an IL-10-dependent mechanism. J Clin Invest (2013) 1.12

Comparison of nonviral transfection and adeno-associated viral transduction on cardiomyocytes. Mol Biotechnol (2004) 1.08

Genetic Cre-loxP assessment of epicardial cell fate using Wt1-driven Cre alleles. Circ Res (2012) 1.02

Additive effect of AAV-mediated angiopoietin-1 and VEGF expression on the therapy of infarcted heart. Int J Cardiol (2008) 0.94

Driving vascular endothelial cell fate of human multipotent Isl1+ heart progenitors with VEGF modified mRNA. Cell Res (2013) 0.90

Myocardial angiogenesis after chronic ghrelin treatment in a rat myocardial infarction model. Regul Pept (2012) 0.88

Therapeutic myocardial angiogenesis via vascular endothelial growth factor gene therapy: moving on down the road. Circulation (2000) 0.80

Articles by these authors

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell (2010) 14.18

Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet (2005) 13.77

Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature (2005) 11.23

Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains. PLoS Genet (2008) 11.17

Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science (2009) 10.47

Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med (2007) 9.51

Somatic coding mutations in human induced pluripotent stem cells. Nature (2011) 9.50

Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature (2005) 9.44

Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol (2010) 9.24

Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol (2003) 9.08

Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature (2004) 8.36

Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol (2002) 7.78

Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell (2006) 7.21

Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature (2008) 7.03

Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell (2005) 6.90

Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell (2013) 6.35

Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci U S A (2005) 6.32

Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol (2008) 6.19

Comprehensive methylome map of lineage commitment from haematopoietic progenitors. Nature (2010) 6.06

Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J Exp Med (2005) 5.68

Altered microRNA expression in human heart disease. Physiol Genomics (2007) 5.64

Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy. Cell Stem Cell (2007) 5.28

Isolation of adult mouse myogenic progenitors: functional heterogeneity of cells within and engrafting skeletal muscle. Cell (2004) 5.20

Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell (2007) 5.17

De novo cardiomyocytes from within the activated adult heart after injury. Nature (2011) 5.17

Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles. Cell (2008) 4.92

Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat Cell Biol (2011) 4.77

The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell (2002) 4.72

Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature (2009) 4.68

Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity. Nature (2012) 4.64

Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol (2008) 4.56

Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin. Cancer Cell (2006) 4.55

Myocardial infarction accelerates atherosclerosis. Nature (2012) 4.48

Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc Natl Acad Sci U S A (2003) 4.41

Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. Nature (2006) 4.35

Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. Am J Pathol (2006) 4.32

IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat Immunol (2003) 4.25

Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation (2007) 4.20

Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med (2013) 4.14

Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol (2011) 3.95

An Nkx2-5/Bmp2/Smad1 negative feedback loop controls heart progenitor specification and proliferation. Cell (2007) 3.74

Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511. Nat Biotechnol (2010) 3.70

Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat Med (2004) 3.63

Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature (2002) 3.60

Adult cardiac-resident MSC-like stem cells with a proepicardial origin. Cell Stem Cell (2011) 3.56

The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/beta-catenin pathway. Cell Stem Cell (2007) 3.54

Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat. Proc Natl Acad Sci U S A (2010) 3.54

Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation (2007) 3.51

No place like home: anatomy and function of the stem cell niche. Nat Rev Mol Cell Biol (2008) 3.46

Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc Natl Acad Sci U S A (2010) 3.41

Ephrin-B2 and EphB1 mediate retinal axon divergence at the optic chiasm. Neuron (2003) 3.39

Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors. Science (2014) 3.37

ErbB2 is essential in the prevention of dilated cardiomyopathy. Nat Med (2002) 3.36

Braveheart, a long noncoding RNA required for cardiovascular lineage commitment. Cell (2013) 3.35

Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care (2007) 3.29

Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science (2013) 3.22

Retracted Systemic signals regulate ageing and rejuvenation of blood stem cell niches. Nature (2010) 3.21

Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation (2004) 3.20

Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study. Crit Care (2007) 3.19

Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart. Proc Natl Acad Sci U S A (2011) 3.18

Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass. J Am Coll Cardiol (2011) 3.17

Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science (2014) 3.14

Epicardial retinoid X receptor alpha is required for myocardial growth and coronary artery formation. Proc Natl Acad Sci U S A (2005) 3.13

Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. Proc Natl Acad Sci U S A (2002) 3.13

Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int (2008) 3.12

Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nat Nanotechnol (2012) 3.09

A special population of regulatory T cells potentiates muscle repair. Cell (2013) 3.09

Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int (2011) 3.05

Blood monocyte subsets differentially give rise to CD103+ and CD103- pulmonary dendritic cell populations. J Immunol (2008) 3.04

Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol (2010) 3.03

Absence epilepsy and sinus dysrhythmia in mice lacking the pacemaker channel HCN2. EMBO J (2003) 3.02

NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol (2007) 2.99

Adult mouse epicardium modulates myocardial injury by secreting paracrine factors. J Clin Invest (2011) 2.99

Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc Natl Acad Sci U S A (2011) 2.96

Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol (2004) 2.96

Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J Exp Med (2002) 2.96

Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J Exp Med (2012) 2.92

Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell (2012) 2.91

Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol (2004) 2.91

Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis. J Am Coll Cardiol (2010) 2.90

The transcription factor EGR1 controls both the proliferation and localization of hematopoietic stem cells. Cell Stem Cell (2008) 2.88

Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes. PLoS One (2008) 2.85

Retracted Osteolineage niche cells initiate hematopoietic stem cell mobilization. Blood (2008) 2.84

Dishevelled 2 is essential for cardiac outflow tract development, somite segmentation and neural tube closure. Development (2002) 2.71

Lives of a heart cell: tracing the origins of cardiac progenitors. Cell Stem Cell (2008) 2.68

DNA methylation dynamics during in vivo differentiation of blood and skin stem cells. Mol Cell (2012) 2.66

Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell (2004) 2.64

Generation of functional ventricular heart muscle from mouse ventricular progenitor cells. Science (2009) 2.60